Persistent reduction of endothelial desquamation in patients with diabetes mellitus
pdf (Українська)

Keywords

diabetes mellitus, endothelial desquamation, diabetic microangiopathy, circulating endothelial cells.

How to Cite

Kuznetsova, H., Gozhenko, A., Kuznetsova, K., Bobryk, L., & Kuznetsov, S. (2019). Persistent reduction of endothelial desquamation in patients with diabetes mellitus. Endokrynologia, 24(3), 217-222. https://doi.org/10.31793/1680-1466.2019.24-3.217

Abstract

The results of a clinical study of endothelial damage in patients with type 1 and type 2 diabetes mellitus (DM) are presented in the article. Aim — is to determine the nature and changes in the endothelial desquamation due to normalization of glycemia and the correction of concomitant pathology in patients with type 1 and 2 diabetes. Material and methods. 50 patients with type 1 and type 2 DM were involved in the study. Endothelial desquamation intensity was determined by modified Hladovec J. method. Results. Initially, the level of was 2530±694 cells/ml endotheliocytemia in patients with diabetes. Prescribed hypoglycemic therapy was associated with a clinically significant improvement of glycemic control — the average HbA1c level decreased from 8.42±0.2% to
7.36±0.3% (p<0.001). In three months from the beginning of the study, the level of circulating endothelial cells was established to be 32.57% lover with an average mean of 1706±58.9 cells/ml (p<0.001). The statistically significant difference in the level of endothelial desquamation between patients with type 1 and type 2 DM was not detected at all stages of the study.

https://doi.org/10.31793/1680-1466.2019.24-3.217
pdf (Українська)

References

1. Saeedi Borujeni MJ, Esfandiary E, Taheripak G, Codoñer-Franch P, Alonso-Iglesias E, Mirzaei H. Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome. J Cell Biochem. 2018; 119(2): 1257-72.
2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics — 2016 update. A report from the American Heart Association. Circulation. 2016; 133(4): e38-360.
3. Gozhenko AI, Kuznetsova HS, Kuznetsov SH, Kuznetsova KS, Byts TM. The number of circulating endotheliocytes in the blood plasma of the patients with diabetes mellitus increases Pharmacologyonline, 2017; 3: 23-6.
4. Omidian М, Abshirini М, Djalali М, Omidian Р, Zarei М, Hasani Н, Djalali М. The effects of vitamin D supplementation on serum levels and gene expression of some inflammatory and endothelial biomarkers in patients with type‑2 diabetes mellitus: a study protocol for a randomized double-blind controlled trial. IOSR J Pharmacy (IOSRPHR), 2019; 9(1): 06-11.
5. Kuznetsova HS, Kuznetsova KS, Byts TM, Bobryk LM, Kuznetsova OM, Gozhenko AI. Mechanisms of regeneration of the endothelium at diabetes mellitus. Endokrinolohiya. 2018; 23(4): 384-90.
6. Кузнецова АС, Гоженко АИ, Кузнецова ЕС, Шухтин ВВ, Кузнецова ЕН, Кузнецов СГ. Эндотелий. Физиология и патология: монография. Одесса: «Феникс», 2018. 284 с. (Kuznetsova AS, Gozhenko AI, Byts TM, Bobryk LM, Kuznetsova OM, Kuznetsova SG. Endothelium. Physiology and pathology: monograph. Odessa: Phoenix, 2018. 284 p.).
7. Гоженко АИ, Кузнецова АС, Кузнецова ЕС, Быць ТН, Сусла А.Б. Эндотелиальная дисфункция в патогенезе осложнений сахарного диабета. Сообщение I. Эндотелиальная дисфункция: этиология, патогенез и методы диагностики. Ендокринологія. 2017; 22 (2): 171-81. (Gozhenko AI, Kuznetsova AS, Kuznetsova ES, Byts TN, Susla AB. Endothelial dysfunction in the pathogenesis of diabetes complications. Report I. Endothelial dysfunction: etiology, pathogenesis and diagnostic methods. Endokrinologiya. 2017; 22 (2): 171-81).
8. Гоженко АИ, Кузнецова АС, Кузнецова ЕС, Кузнецова ЕН, Быць ТН, Жуков В. Морфо-функциональные основы эндотелиальной дисфункции при сахарном диабете. J Educ, Health and Sport. 2017; 7(6): 516-24. (Gozhenko AI, Kuznetsova AS, Kuznetsova YeS, Kuznetsova YeN, Byts TN, Zhukov B. Morpho-functional basis of endothelial dysfunction in diabetes mellitus. J Educ, Health and Sport. 2017;7(6):516-24).
9. https://www.plotus.xyz/ Программа анализа и визуализации данных.
10. Шафран ЛМ, Третьякова ОВ, Потапов ЄА, винахідники; Шафран ЛМ, Третьякова ОВ, Потапов ЄА, патентовласники. Спосіб визначення ендотеліальної дисфункції. Патент України № 125773. 2018 трав. 25.
11. Кузнецова АС, Кузнецова ЕС, Быць ТН, Кузнецова ЕН, Демидов СМ, Поветкина ТН, Гоженко АИ. Характеристики эндотелиальной дисфункции у больных сахарным диабетом. Актуальные проблемы транспортной медицины. 2018; 2(52): 116-22. (Kuznetsova AS, Kuznetsova YES, Byts’ TN, Kuznetsova
YеN, Demidov SM, Povetkina TN, Gozhenko AI. Characteristics of endothelial dysfunction in patients with diabetes mellitus. Aktual’nyye problemy transportnoy meditsiny. 2018; 2(52): 116-22).

Downloads

Download data is not yet available.